Id2-Mediated Inhibition of E2A Represses Memory CD8+ T Cell Differentiation
Author(s) -
Frédérick Masson,
Martina Minnich,
Moshe Olshansky,
Ivan Bilić,
Adele M. Mount,
Axel Kallies,
Terence P. Speed,
Meinrad Busslinger,
Stephen L. Nutt,
Gabrielle T. Belz
Publication year - 2013
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.1300099
Subject(s) - effector , transcription factor , microbiology and biotechnology , cellular differentiation , cytotoxic t cell , cd8 , biology , cell fate determination , psychological repression , memory t cell , t cell , gene expression , immunology , genetics , gene , immune system , in vitro
The transcription factor inhibitor of DNA binding (Id)2 modulates T cell fate decisions, but the molecular mechanism underpinning this regulation is unclear. In this study we show that loss of Id2 cripples effector differentiation and instead programs CD8(+) T cells to adopt a memory fate with increased Eomesodermin and Tcf7 expression. We demonstrate that Id2 restrains CD8(+) T cell memory differentiation by inhibiting E2A-mediated direct activation of Tcf7 and that Id2 expression level mirrors T cell memory recall capacity. As a result of the defective effector differentiation, Id2-deficient CD8(+) T cells fail to induce sufficient Tbx21 expression to generate short-lived effector CD8(+) T cells. Our findings reveal that the Id2/E2A axis orchestrates T cell differentiation through the induction or repression of downstream transcription factors essential for effector and memory T cell differentiation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom